Up0122 106 is a clinical research site located in Chapel Hill, North Carolina, United States 27516.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Up0122 106 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis.
Sponsors: UCB Biopharma SRL.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Up0122 106 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Up0122 106 has 1 clinical trials on record, with 1 currently active. Their work covers Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis.
Up0122 106 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.